Bio Pharma Dive
MAY 24, 2022
One day after the U.S. began releasing supplies of an approved Bavarian Nordic shot, Moderna said it's beginning development of its own vaccine against the virus.
World of DTC Marketing
MAY 24, 2022
Cerebral will stop writing prescriptions for Adderall, Ritalin, and other controlled substances to new ADHD patients as concerns grow about telehealth companies’ prescribing practices. To make matters worse, a former executive at Cerebral, a well-funded online mental health startup, claims in a labor lawsuit that the company fired him after he complained that the company was too quick to prescribe powerful stimulant drugs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Worldwide Clinical Trials
MAY 24, 2022
Life after cancer is about more than just survival. It’s not just the length of life that matters, but also the quality of that life. Join us as we celebrate cancer research awareness month and clinical trials awareness month. Building Bridges. Where I trained at the University of Maryland, there was literally a bridge that connected the research labs to the clinic.
Bio Pharma Dive
MAY 24, 2022
The biotech plans to seek FDA approval for its soft-tissue tumor treatment after positive study results. But investors still sent the stock down by nearly 10%.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Drug Channels
MAY 24, 2022
A few weeks ago, GoodRx surprised investors with the unpleasant news that a major grocery chain had stopped accepting its discount card for an unspecified number of prescriptions. As I explain below, the unnamed chain appears to be Kroger— the sixth-largest U.S. pharmacy. What’s more, GoodRx disclosed that Kroger accounts for an unexpected one-quarter of its prescription business.
Bio Pharma Dive
MAY 24, 2022
The two companies are each developing new types of medicines that they hope can soon win FDA approval for treating the autoimmune disease.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
MAY 24, 2022
Industrial action at several GlaxoSmithKline manufacturing plants in the UK has been called off, after an improved pay deal was accepted by the Unite union. Unite said last month it was calling for strike by GSK workers for the first time in the company’s history, saying a “derisory” 2.75% pay increase was in fact a pay cut in real terms given the rising rate of inflation in the UK, currently at around 9%.
Scienmag
MAY 24, 2022
BIRMINGHAM, Ala. – Small interfering RNAs, or siRNAs, hold promise to treat tumors, through their ability to specifically knock down oncogenes that promote tumor growth, without the toxicity that accompanies chemotherapy. However, the siRNAs need a delivery vehicle to protect them from degradation and clearance on their journey through the bloodstream to the cancer tumor. […].
Pharma Times
MAY 24, 2022
Less invasive procedure offers an equally effective alternative for heart condition patients
Scienmag
MAY 24, 2022
Rubber from used tyres acts like sunscreen for roads and halves the rate of sun damage when mixed with bitumen, new research has found.? Credit: RMIT University Rubber from used tyres acts like sunscreen for roads and halves the rate of sun damage when mixed with bitumen, new research has found.? Engineers at RMIT University […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Outsourcing Pharma
MAY 24, 2022
The drug company, which uses artificial intelligence to discover and advance repurposed drugs, is harnessing the technology to find a treatment for Crohnâs.
Scienmag
MAY 24, 2022
When administered soon after the onset of acute ischemic stroke, current approved treatments for the condition can dramatically improve patient outcomes. However, not all patients are cured, and approved treatments also carry risks, including cerebral hemorrhage or bleeding into the brain. Credit: USC/Don Milci When administered soon after the onset of acute ischemic stroke, current […].
pharmaphorum
MAY 24, 2022
The World Health Organization has said the current outbreak of monkeypox is the largest ever recorded outside sub-Saharan Africa, with cases rising above the 100-mark a few days ago and the UK top of the table with 56 as of yesterday. Top of the list of concerns is how the virus – which does not spread easily between humans and requires skin-to-skin contact – is spreading so quickly in so many countries in Europe, the Americas and Australia where the disease is not endemic.
Scienmag
MAY 24, 2022
Machine learning, meaning the ability to recognize important patterns in data sets and to generate solutions with the help of algorithms, is a research field of rapidly growing importance. In physics, chemistry and biology with complex molecular structures, classical machine learning is reaching its limits. In order to better understand and use molecular data, new […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
MAY 24, 2022
Companies say that three-dose vaccine for children aged six months to five years old is 80% effective at preventing illness
Scienmag
MAY 24, 2022
Scientists have demonstrated that normal brain aging is accelerated by approximately 26% in people with progressive type 2 diabetes compared with individuals without the disease, reports a study published today in eLife. Credit: Lilianne Mujica-Parodi (CC BY 4.0) Scientists have demonstrated that normal brain aging is accelerated by approximately 26% in people with progressive type […].
pharmaphorum
MAY 24, 2022
AbbVie has reported new phase 3 data for its schizophrenia and bipolar disorder therapy Vraylar in treatment-resistant depression, as it waits for a decision by the FDA on the new indication. The drugmaker filed Vraylar (cariprazine) as an add-on to conventional antidepressant therapy in people with MDD who may be struggling to control symptoms using the antidepressant alone in February, with a decision expected by the end of the year.
Scienmag
MAY 24, 2022
UC Riverside scientists have a new chemical weapon to seduce and kill the invasive, long-nosed beetles destroying California palm trees by the tens of thousands. Credit: Mark Hoddle/UCR UC Riverside scientists have a new chemical weapon to seduce and kill the invasive, long-nosed beetles destroying California palm trees by the tens of thousands. The weapon […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
MAY 24, 2022
Eli Lilly has the results it was looking for in a second, confirmatory trial of its anti-IL-23p19 antibody mirikizumab in ulcerative colitis as it waits for the outcome of regulatory reviews in the US and EU. The results of the LUCENT-2 trial presented today at Digestive Disease Week (DDW) meeting found that among patients with UC who responded to the drug at 12 weeks, 49.9% remained in clinical remission after a year’s follow-up compared to 25.1% of those on placebo.
Scienmag
MAY 24, 2022
Origami, the Japanese art of folding paper into decorative shapes and figures, has long served as inspiration for industrial design. The concept of folding has been used to build reconfigurable structures, which change their function by changing their shape. These structures are promising for applications such as nanorobots for drug delivery, foldable solar panels for […].
Pharma Marketing Network
MAY 24, 2022
Tune in to this episode of the Pharma Marketing Podcast with Bharti Rai, Novartis VP, Chief Commercial Operations, Insight, Analytics Officer Data & Digital, for a deeper dive into what’s ahead for 1st and 3rd party data, insights, analytics & digital data. The post What’s Ahead for 1st and 3rd party data, Insights, Analytics & Digital Data Video appeared first on Pharma Marketing Network.
Scienmag
MAY 24, 2022
New experiments conducted in mice add to mounting evidence in opposition to a popular claim that COVID-19 vaccination during early pregnancy may cause birth defects or fetal growth problems. The study also counters claims that COVID-19 vaccines reduce fertility through their effects on the protein syncytin-1. Alice Lu-Culligan of the Yale School of Medicine, US, […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Drug Patent Watch
MAY 24, 2022
Annual Drug Patent Expirations for RYDAPT Rydapt is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting…. The post New patent for Novartis drug RYDAPT appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
MAY 24, 2022
Steven Kachelmeier has been named chair of The University of Texas at Austin McCombs School of Business Department of Accounting, effective Sept. 1. Credit: University of Texas Steven Kachelmeier has been named chair of The University of Texas at Austin McCombs School of Business Department of Accounting, effective Sept. 1. Kachelmeier joined the McCombs faculty […].
Imperical Blog
MAY 24, 2022
The Outsourcing In Clinical Trials (OCT) Europe conference held in Barcelona was fully face-to-face. No prerecorded talks! A conference hall heavy with exhibitors for clinical studies. With hundreds of delegates walking around laughing and chatting, all enjoying the return to business as usual! In-person conferences… The post Fresh Initiatives Revealed for Clinical Studies appeared first on Imperial Clinical Research Services Blog.
Scienmag
MAY 24, 2022
Around the world, hundreds of millions of acres of land are being abandoned due to what’s known as “rural outmigration,” or people leaving for urban centers. Some people leave in search of economic prosperity. Others are forced out due to conflict or the effects of climate change. Together with globalization and mechanization, these population shifts […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
pharmaphorum
MAY 24, 2022
As healthcare evolves to become more consumer-centric, the value of social health – the dynamic, real-time action people take to find meaningful connections and share information that impact the health journey – becomes more essential. When properly executed, social health interactions can be leveraged to create mutually beneficial impact for both patients and pharma.
Scienmag
MAY 24, 2022
During fetal development, before the biological clock starts ticking on its own, genes within the fetus’s developing clock respond to rhythmic behavior in the mother, according to a new study publishing May 24th in the open-access journal PLOS Biology by Alena Sumová and colleagues of the Czech Academy of Sciences in Prague. The findings contribute […].
pharmaphorum
MAY 24, 2022
Value is a tricky concept to capture accurately. Given the diverse and complex world that we live in, different people will often hold contrasting views of what constitutes value. Identifying and measuring value is a particularly interesting quandary for life sciences companies, as inevitably each of these viewpoints will interact with the industry in some way, shape or form.
Scienmag
MAY 24, 2022
The brain is made up of a complex series of networks—signals are constantly bouncing between those networks to allow us to experience the world and move through it effectively. Credit: Nicholas Card / University of Pittsburgh The brain is made up of a complex series of networks—signals are constantly bouncing between those networks to allow […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
344 
Let's personalize your content